The EBMT activity survey: 1990–2010 von Passweg, J R, Baldomero, H, Gratwohl, A, Bregni, M, Cesaro, S, Dreger, P, Witte, T de, Farge-Bancel, D, Gaspar, B, Marsh, J, Mohty, M, Peters, C, Tichelli, A, Velardi, A, de Elvira, C Ruiz, Falkenburg, F, Sureda, A, Madrigal, A

Volltext

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 von Ljungman, P, Bregni, M, Brune, M, Cornelissen, J, Witte, T de, Dini, G, Einsele, H, Gaspar, H B, Gratwohl, A, Passweg, J, Peters, C, Rocha, V, Saccardi, R, Schouten, H, Sureda, A, Tichelli, A, Velardi, A, Niederwieser, D

Volltext

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials von Platzbecker, U., Fenaux, P., Adès, L., Giagounidis, A., Santini, V., van de Loosdrecht, A.A., Bowen, D., de Witte, T., Garcia-Manero, G., Hellström-Lindberg, E., Germing, U., Stauder, R., Malcovati, L., Sekeres, Mikkael A., Steensma, David P., Gloaguen, S.

Volltext

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice von Ruutu, T, Gratwohl, A, de Witte, T, Afanasyev, B, Apperley, J, Bacigalupo, A, Dazzi, F, Dreger, P, Duarte, R, Finke, J, Garderet, L, Greinix, H, Holler, E, Kröger, N, Lawitschka, A, Mohty, M, Nagler, A, Passweg, J, Ringdén, O, Socié, G, Sierra, J, Sureda, A, Wiktor-Jedrzejczak, W, Madrigal, A, Niederwieser, D

Volltext

Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis von Stern, M, de Wreede, L C, Brand, R, van Biezen, A, Dreger, P, Mohty, M, de Witte, T M, Kröger, N, Ruutu, T

Volltext

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT von Ruutu, T, de Wreede, L C, van Biezen, A, Brand, R, Mohty, M, Dreger, P, Duarte, R, Peters, C, Garderet, L, Schönland, S, Gratwohl, A, Niederwieser, D, de Witte, T, Kröger, N

Volltext

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings von Kröger, N, Zabelina, T, de Wreede, L, Berger, J, Alchalby, H, van Biezen, A, Milpied, N, Volin, L, Mohty, M, Leblond, V, Blaise, D, Finke, J, Schaap, N, Robin, M, de Witte, T

Volltext

Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome von Garelius, H. K. G., Johnston, W. T., Smith, A. G., Park, S., de Swart, L., Fenaux, P., Symeonidis, A., Sanz, G., Čermák, J., Stauder, R., Malcovati, L., Mittelman, M., van de Loosdrecht, A. A., van Marrewijk, C. J., Bowen, D., Crouch, S., de Witte, T. J. M., Hellström‐Lindberg, E.

Volltext

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBM... von Martino, R, de Wreede, L, Fiocco, M, van Biezen, A, von dem Borne, P A, Hamladji, R-M, Volin, L, Bornhäuser, M, Robin, M, Rocha, V, de Witte, T, Kröger, N, Mohty, M

Volltext

Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation von Ruutu, T, van Biezen, A, Hertenstein, B, Henseler, A, Garderet, L, Passweg, J, Mohty, M, Sureda, A, Niederwieser, D, Gratwohl, A, de Witte, T

Volltext

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT von Chalandon, Y, Passweg, J R, Schmid, C, Olavarria, E, Dazzi, F, Simula, M P, Ljungman, P, Schattenberg, A, Witte, T de, Lenhoff, S, Jacobs, P, Volin, L, Iacobelli, S, Finke, J, Niederwieser, D, Guglielmi, C

Volltext

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related dono... von Martino, R, Henseler, A, van Lint, M, Schaap, N, Finke, J, Beelen, D, Vigouroux, S, Alessandrino, E P, Mufti, G J, Veelken, J H, Bruno, B, Yakoub-Agha, I, Volin, L, Maertens, J, Or, R, Leblond, V, Rovira, M, Kalhs, P, Alvarez, A F, Vitek, A, Sierra, J, Wagner, E, Robin, M, de Witte, T, Kröger, N

Volltext

Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia von van Gelder, M, de Wreede, L C, Schetelig, J, van Biezen, A, Volin, L, Maertens, J, Robin, M, Petersen, E, de Witte, T, Kröger, N

Volltext

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of t... von Robin, M, Porcher, R, Zinke-Cerwenka, W, van Biezen, A, Volin, L, Mufti, G, Craddock, C, Finke, J, Richard, C, Passweg, J, Peniket, A, Maertens, J, Sucak, G, Gedde-Dahl, T, Vitek, A, Nagler, A, Blaise, D, Beelen, D, Maillard, N, Schwerdtfeger, R, de Witte, T, Kroger, N

Volltext

Dynamic Pseudo‐Observations: A Robust Approach to Dynamic Prediction in Competing Risks von Nicolaie, M. A, van Houwelingen, J. C, de Witte, T. M, Putter, H

Volltext

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for... von Auner, H W, Szydlo, R, van Biezen, A, Iacobelli, S, Gahrton, G, Milpied, N, Volin, L, Janssen, J, Nguyen Quoc, S, Michallet, M, Schoemans, H, el Cheikh, J, Petersen, E, Guilhot, F, Schönland, S, Ahlberg, L, Morris, C, Garderet, L, de Witte, T, Kröger, N

Volltext

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Conso... von Wiktor-Jedrzejczak, W, Dearden, C, de Wreede, L, van Biezen, A, Brinch, L, Leblond, V, Brune, M, Volin, L, Kazmi, M, Nagler, A, Schetelig, J, de Witte, T, Dreger, P

Volltext

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden von Blijlevens, N, de Château, M, Krivan, G, Rabitsch, W, Szomor, A, Pytlik, R, Lissmats, A, Johnsen, H E, de Witte, T, Einsele, H, Ruutu, T, Niederwieser, D

Volltext

The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis von Ruutu, T, Gratwohl, A, Niederwieser, D, de Witte, T, van der Werf, S, van Biezen, A, Mohty, M, Kröger, N, Rambaldi, A, McGrath, E, Sureda, A, Basak, G, Greinix, H, Duarte, R F

Volltext

Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis von Schönland, S O, Dreger, P, de Witte, T, Hegenbart, U

Volltext